Recursion

Recursion is a clinical-stage biotechnology company that uses an AI-driven discovery platform (Recursion OS) combining high-throughput biology, chemistry, and computation to discover and develop new medicines. It advances an internal pipeline and forms discovery and development partnerships with biopharma across oncology, immunology and inflammation, and rare diseases. Founded in 2013 and headquartered in Salt Lake City, it is a public company listed on NASDAQ (RXRX).